Your hard-earned money would be better spent elsewhere.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

And that could be a good thing ...

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

The market trades near all-time highs with extreme valuations, driven by passive investing and questionable underlying ...

Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, ...

These local LLMs are changing the game in lots of fun ways.

Magic: The Gathering’s new Marvel Super Heroes set is here, and as you can probably imagine, it’s absolutely packed with ...